| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.089 | 0.004 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |